DA

Di An

Executive Director, Head Of Biostatistics Rare Diseases at Acadia Pharmaceuticals

Di An is an experienced professional in the field of biostatistics and rare diseases. They have held various leadership roles in biostatistics at companies such as Acadia Pharmaceuticals Inc., Intercept Pharmaceuticals, Gilead Sciences, and Merck & Co., Inc. Di An holds a Ph.D. in Biostatistics from the University of Michigan and a M.S. in Statistics from Texas A&M University.

Location

San Diego, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Acadia Pharmaceuticals

3 followers

Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.


Industries

Employees

501-1,000

Links